No Haploinsufficiency but Loss of Heterozygosity for EXT in Multiple Osteochondromas
نویسندگان
چکیده
منابع مشابه
Multiple osteochondromas
Multiple osteochondromas (MO) is characterised by development of two or more cartilage capped bony outgrowths (osteochondromas) of the long bones. The prevalence is estimated at 1:50,000, and it seems to be higher in males (male-to-female ratio 1.5:1). Osteochondromas develop and increase in size in the first decade of life, ceasing to grow when the growth plates close at puberty. They are pedu...
متن کاملSelection on heritable heterozygosity but no response to selection. Why?
The realisation that heterozygosity can be heritable has recently generated some elegant research. However, none of this work has discussed the fact that when heterozygote advantage occurs, heterozygosity can be heritable, yet allele frequencies remain at equilibrium and do not evolve with time. From a quantitative genetic perspective this means the character is heritable, is under selection, y...
متن کاملLoss of heterozygosity in tuberous sclerosis hamartomas.
We have previously described in tuberous sclerosis (TSC) hamartomas the phenomenon of loss of heterozygosity (LOH) for DNA markers in the region of both the TSC2 gene on chromosome 16p13.3 and the TSC1 gene on 9q34. We now describe the spectrum of LOH in 51 TSC hamartomas from 34 cases of TSC. DNA was extracted from leucocytes or normal paraffin embedded tissue, and from frozen paraffin embedde...
متن کاملLoss of somatic heterozygosity in hepatocellular carcinoma.
Loss of tumor suppressor genes is involved in the mechanism of tumorigenesis of many solid tumors. We tested 9 hepatitis B virus (HBV)-positive and 10 HBV-negative hepatocellular carcinomas for loss of somatic heterozygosity using 14 polymorphic probes mapping to chromosomes 4, 11, 13, and 17. Losses were found on all chromosome arms tested. The highest frequency of loss was observed at the D13...
متن کاملLoss of heterozygosity in laryngeal cancer.
PURPOSE Head and neck cancers account for about 6% of all human cancers. Molecular changes leading to the disease development and progression still remain not fully explained. Examination of loss of heterozygosity (allelic loss, LOH) using the specific microsatellite markers is a method of choice in assessing tumour suppressor genes (TSGs) localisation in human genome. MATERIAL AND METHODS Th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The American Journal of Pathology
سال: 2010
ISSN: 0002-9440
DOI: 10.2353/ajpath.2010.100296